Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Matthew J. Wong"'
Autor:
Victor M. Rivera, Tim Clackson, Frank Wang, William C. Shakespeare, Narayana I. Narasimhan, Qurish K. Mohemmad, Scott Wardwell, Lauren Moran, Matthew J. Wong, Joseph M. Gozgit
Members of the fibroblast growth factor receptor family of kinases (FGFR1–4) are dysregulated in multiple cancers. Ponatinib (AP24534) is an oral multitargeted tyrosine kinase inhibitor being explored in a pivotal phase II trial in patients with ch
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f39a803ac9fd251dac4bfc2513c8a34
https://doi.org/10.1158/1535-7163.c.6536118
https://doi.org/10.1158/1535-7163.c.6536118
Autor:
Victor M. Rivera, Tim Clackson, Frank Wang, William C. Shakespeare, Narayana I. Narasimhan, Qurish K. Mohemmad, Scott Wardwell, Lauren Moran, Matthew J. Wong, Joseph M. Gozgit
PDF file - 89K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::204d870cea2dd90df5ac2f4c153a4b22
https://doi.org/10.1158/1535-7163.22499316.v1
https://doi.org/10.1158/1535-7163.22499316.v1
Autor:
Victor M. Rivera, Tim Clackson, Frank Wang, William C. Shakespeare, Narayana I. Narasimhan, Qurish K. Mohemmad, Scott Wardwell, Lauren Moran, Matthew J. Wong, Joseph M. Gozgit
PDF file - 457K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73384c8e889704535b231a4ea75b9e5d
https://doi.org/10.1158/1535-7163.22499319.v1
https://doi.org/10.1158/1535-7163.22499319.v1
Autor:
Victor M. Rivera, Tim Clackson, Frank Wang, William C. Shakespeare, Narayana I. Narasimhan, Qurish K. Mohemmad, Scott Wardwell, Lauren Moran, Matthew J. Wong, Joseph M. Gozgit
PDF file - 73K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::816075e43e2bad27f4b2ca0728a4e436
https://doi.org/10.1158/1535-7163.22499313
https://doi.org/10.1158/1535-7163.22499313
Autor:
Matthew J. Wong
Aluminum alloyed with small atomic fractions of Sc, Zr, and Hf has been shown to exhibit high temperature microstructural stability that may improve high temperature mechanical behavior. These quaternary alloys were designed using thermodynamic model
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::45078cb960c26d04ae49096e144d0d37
https://doi.org/10.37099/mtu.dc.etds/870
https://doi.org/10.37099/mtu.dc.etds/870
Autor:
Lucia Taraborrelli, Yasin Şenbabaoğlu, Lifen Wang, Junghyun Lim, Kerrigan Blake, Noelyn Kljavin, Sarah Gierke, Alexis Scherl, James Ziai, Erin McNamara, Mark Owyong, Shilpa Rao, Aslihan Karabacak Calviello, Daniel Oreper, Suchit Jhunjhunwala, Guillem Argiles, Johanna Bendell, Tae Won Kim, Fortunato Ciardiello, Matthew J. Wongchenko, Frederic J. de Sauvage, Felipe de Sousa e Melo, Yibing Yan, Nathaniel R. West, Aditya Murthy
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-17 (2023)
Abstract Microsatellite-stable colorectal cancer (MSS-CRC) is highly refractory to immunotherapy. Understanding tumor-intrinsic determinants of immunotherapy resistance is critical to improve MSS-CRC patient outcomes. Here, we demonstrate that high t
Externí odkaz:
https://doaj.org/article/60a294e8ef9e4b37a641c0c3e8919afe
Publikováno v:
Metallurgical and Materials Transactions A. 46:2947-2955
In a number of nickel-based superalloy systems strengthened by gamma prime (γ′), eta-phase (Ni3Ti, η) forms during prolonged high-temperature exposure, but its effect on mechanical properties is not well characterized. Using thermodynamic modelin
Autor:
Michael Heinrich, Laura McGreevey, Richard D. Press, Michael W. Deininger, Daniel W. Sherbenou, A Humayun, Patina Harrell, Michael J. Mauro, Brian J. Druker, Rui Yang, Matthew J. Wong
Publikováno v:
Leukemia. 21:489-493
Residual leukemia is demonstrable by reverse transcriptase-polymerase chain reaction in most patients with chronic myeloid leukemia who obtain a complete cytogenetic response (CCR) to imatinib. In patients who relapse during imatinib therapy, a high
Autor:
Joseph M. Gozgit, Lauren Moran, Scott Wardwell, Frank Wang, Tim Clackson, William C. Shakespeare, Qurish K. Mohemmad, Matthew J. Wong, Narayana I. Narasimhan, Victor M. Rivera
Publikováno v:
Molecular cancer therapeutics. 11(3)
Members of the fibroblast growth factor receptor family of kinases (FGFR1–4) are dysregulated in multiple cancers. Ponatinib (AP24534) is an oral multitargeted tyrosine kinase inhibitor being explored in a pivotal phase II trial in patients with ch
Autor:
Joseph M. Gozgit, Tim Clackson, Matthew J. Wong, Marc M. Loriaux, Victor M. Rivera, Jeffrey W. Tyner, Brian J. Druker, William C. Shakespeare, Qurish K. Mohemmad, Scott Wardwell, Narayana I. Narasimhan, Frank Wang
Ponatinib (AP24534) is a novel multitargeted kinase inhibitor that potently inhibits native and mutant BCR-ABL at clinically achievable drug levels. Ponatinib also has in vitro inhibitory activity against a discrete set of kinases implicated in the p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b53c5600938febc32e1d28752e778ef3
https://europepmc.org/articles/PMC3236248/
https://europepmc.org/articles/PMC3236248/